Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...

HHS announced a sweeping effort aimed at strengthening America's role in clinical research, accelerating the development of new treatments.

The partnership aims to increase trial efficiency, expand patient access to therapies, and support new discoveries.

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

The agency says pairing drug sponsors with research institutions could cut development timelines by 6 to 12 months ...

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola ...

The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...